E.g., 03/29/2024
E.g., 03/29/2024
Titlesort descending Program description Type Credit Event date
Pharmacy Podcast Episode 132 : Pharmacotherapy for the Treatment of Obesity

Available until September 1, 2024 - Podcast Online CME Education

Kristina M. Thurber, PharmD, BCPS recognizes pharmacotherapy for the treatment of obesity and explain mechanisms of action for each class, discusses and compares clinical data and weight loss outcomes for common treatment options, and determines an optimal pharmacologic regimen for the treatment of obesity given patient-specific factors.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 133 : Emerging Antibiotics – Tetra(cycle)ine Back to Basics

Available until September 1, 2024 - Podcast Online CME Education

Ashton C. Praska, PharmD describes tetracycline resistance mechanisms utilized by bacteria, identifies how Omadacycline/Eravacycline can overcome common tetracycline resistance mechanisms and identifies clinical scenarios where Omadacycline/Eravacycline could be considered for use.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 134 : Freezing Ethylene Glycol Toxicity

Available until September 1, 2024 - Podcast Online CME Education

Kamryn R. Storm, PharmD outlines the mechanism of toxicity for ethylene glycol, identifies clinical findings of ethylene glycol toxicity and selects treatment regimens for suspected ethylene glycol toxicity.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 135 : A Hard-Pressed Debate: The Role of Terlipressin in Hepatorenal Syndrome

Available until September 1, 2024 - Podcast Online CME Education

Nikitha Yagnala, PharmD and Andy J. Jatis, PharmD, BCPS describe the pathophysiology of hepatorenal syndrome (HRS), describe the pathophysiology of hepatorenal syndrome (HRS) and outline an optimal patient care plan for the management of HRS.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 136 : Verification Decision Support: May AI Take Your Order?

Available until September 1, 2024 - Podcast Online CME Education

Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 137 : Measuring Value in Drug Therapy

Available until September 1, 2024 - Podcast Online CME Education

Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 138 : All-In on Insulin? Use of High-Dose Insulin Euglycemic Therapy in Calcium Channel Blocker Overdose

Available until September 1, 2024 - Podcast Online CME Education

Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 139 : On Another Level: The Role of Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Available until September 1, 2024 - Podcast Online CME Education

Sarah A. Chase, PharmD reviews the pathophysiology and current treatment strategies for inflammatory bowel disease, defines the clinical application of therapeutic drug monitoring of biologic therapies used in inflammatory bowel disease and discusses biologic therapy optimization based on therapeutic drug monitoring.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 140 : Updates on the Clozapine REMS Program: An Important Relic or Fool’s Gold of Safety?

Available until September 1, 2024 - Podcast Online CME Education

Jonathan Leung, PharmD, BCPS, BCPP provides updates on the clozapine REMS program, reviews the therapeutic benefits of clozapine, as well as key adverse events.

Enduring
    • 0.75 AMA PRA Category 1 Credit
    • 0.75 AAPA Category 1
    • 0.75 ACPE
    • 0.75 ANCC
    • 0.75 Attendance
Ongoing
Pharmacy Podcast Episode 141 : Pitter Patter, Let’s Get ATTR: Medications for Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Available until September 1, 2024 - Podcast Online CME Education

Kelli Herrin, PharmD reviews the pathophysiology of transthyretin amyloidosis cardiomyopathy and provides updates on medication options.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 142 : What’s the Best for CRS?

Available until September 1, 2024 - Podcast Online CME Education

Jonathan Leung, PharmD, BCPS, BCPP provides updates on the clozapine REMS program, reviews the therapeutic benefits of clozapine, as well as key adverse events.

Enduring
    • 0.75 AMA PRA Category 1 Credit
    • 0.75 AAPA Category 1
    • 0.75 ACPE
    • 0.75 ANCC
    • 0.75 Attendance
Ongoing
Pharmacy Podcast Episode 143 : Celebrating diversity: challenges and strategies to promote pharmacogenomics translation across populations

Available until September 1, 2024 - Podcast Online CME Education

Serena Mitaly, PharmD shares strategies for pharmacogenomic research translation to reduce health disparities.

Enduring
    • 0.25 AMA PRA Category 1 Credit
    • 0.25 AAPA Category 1
    • 0.25 ACPE
    • 0.25 ANCC
    • 0.25 Attendance
Ongoing
Pharmacy Podcast Episode 144 : What’s Been ‘Flozin On: Updates in Outpatient Management of Chronic Kidney Disease

Available until September 1, 2024 - Podcast Online CME Education

Lauren Stonerock, PharmD describes updates in outpatient management of chronic kidney disease.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 145 : Taking the LEAD? Dual Pathway Inhibition Therapy for Lower Extremity Arterial Disease

Available until September 1, 2024 - Podcast Online CME Education

Shienna Braga, PharmD examines the literature pertaining to dual pathway inhibition for lower extremity arterial disease.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 146 : Give it a Shot! Long-Acting Injectables in HIV Therapy

Available until September 1, 2024 - Podcast Online CME Education

Christopher Cahoon, PharmD elucidates the literature pertaining to injectable cabotegravir and rilpivirine as HIV therapy options.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing

Pages